Focused ultrasound is poised to revolutionize treatment of currently incurable conditions like Parkinson’s disease, reports CNBC.
“A noninvasive treatment option that uses focused ultrasound to mitigate the effects of essential tremor is slowly making its way into hospitals worldwide. University-affiliated medical systems, such as the Mayo Clinic, are currently using it, and more than 1,000 patients with essential tremor around the world have been treated. It’s also being tested further to see how it could be used to treat Parkinson’s disease, Alzheimer’s and to help deliver targeted drug therapy for people suffering from brain tumors. Israel-based Insightec, backed by $400 million of investor capital to date, is the company behind it.”
Get the full story at CNBC.